Avanos Medical, Inc. (AVNS)

Avanos Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	692.5	687.8	673.3	684.1	587	714.8
Revenue Growth (YoY)	1.48%	2.15%	-1.58%	16.54%	-17.88%	2.47%
Cost of Revenue	319.7	306.5	293.6	289.9	287.8	343.9
Gross Profit	372.8	381.3	379.7	394.2	299.2	370.9
Selling, General & Admin	315.8	321.1	321.4	326.5	257.2	327.2
Research & Development	10.3	12.4	12.6	29.2	30.6	34.9
Other Operating Expenses	0.8	3	3.3	3	7.3	4.4
Operating Expenses	326.9	336.5	337.3	358.7	295.1	366.5
Operating Income	45.9	44.8	42.4	35.5	4.1	4.4
Interest Expense	-10.1	-12.2	-15	-10	-3.3	-15.6
Interest & Investment Income	3.6	5.1	2.9	1.2	0.2	1.2
EBT Excluding Unusual Items	39.4	37.7	30.3	26.7	1	-10
Merger & Restructuring Charges	-8.1	-8.1	-28.2	-	-28.1	-25.4
Impairment of Goodwill	-413.5	-336.5	-	-	-	-
Asset Writedown	-100.2	-100.2	-	-	-	-
Legal Settlements	1.4	-	-10	-	-15	-27.5
Other Unusual Items	3.8	3.8	-	-	-	-
Pretax Income	-477.2	-403.3	-7.9	26.7	-42.1	-62.9
Income Tax Expense	-15.9	-17	2	5.2	-11.2	-33.9
Earnings From Continuing Operations	-461.3	-386.3	-9.9	21.5	-30.9	-29
Earnings From Discontinued Operations	-1.9	-5.8	-51.9	29	37.2	-
Net Income	-463.2	-392.1	-61.8	50.5	6.3	-29
Net Income to Common	-463.2	-392.1	-61.8	50.5	6.3	-29
Net Income Growth	-	-	-	701.59%	-	-
Shares Outstanding (Basic)	46	46	47	47	48	48
Shares Outstanding (Diluted)	46	46	47	47	49	48
Shares Change (YoY)	-1.07%	-1.29%	-1.48%	-2.67%	1.67%	0.42%
EPS (Basic)	-10.06	-8.52	-1.33	1.08	0.13	-0.61
EPS (Diluted)	-10.06	-8.53	-1.33	1.08	0.13	-0.61
EPS Growth	-	-	-	722.10%	-	-
Free Cash Flow	87.9	82.9	14.6	71.6	66.3	-22.7
Free Cash Flow Per Share	1.91	1.80	0.31	1.51	1.36	-0.47
Gross Margin	53.83%	55.44%	56.39%	57.62%	50.97%	51.89%
Operating Margin	6.63%	6.51%	6.30%	5.19%	0.70%	0.62%
Profit Margin	-66.89%	-57.01%	-9.18%	7.38%	1.07%	-4.06%
Free Cash Flow Margin	12.69%	12.05%	2.17%	10.47%	11.29%	-3.18%
EBITDA	88.3	90.3	85.9	76.7	42.4	47.3
EBITDA Margin	12.75%	13.13%	12.76%	11.21%	7.22%	6.62%
D&A For EBITDA	42.4	45.5	43.5	41.2	38.3	42.9
EBIT	45.9	44.8	42.4	35.5	4.1	4.4
EBIT Margin	6.63%	6.51%	6.30%	5.19%	0.70%	0.62%
Effective Tax Rate	-	-	-	19.48%	-	-

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q